Читать книгу Transfusion Medicine - Jeffrey McCullough - Страница 189

1 1. Abel JJ, Rowntree LC, Turner BB. Plasma removal with return of corpuscles. J Pharmacol Exp Ther 1914; 5:625–641.

2 2. Kliman A, Gaydos LA, Schroeder LR, Freireich EJ. Repeated plasmapheresis of blood donors as a source of platelets. Blood 1961; 18:303–309.

3 3. McCullough J. Introduction to apheresis donations including history and general principles. In: McLeod B, Price T, Weinstein R, eds. Apheresis: Principles and Practice, 2nd edn. Bethesda, MD: AABB Press, 2003, pp. 29–48.

4 4. Tullis JL, Tinch RJ, Baudanza P, et al. Plateletpheresis in a disposable system. Transfusion 1971; 11:368–377.

5 5. Graw RG, Herzig GP, Eisel RJ, Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 1971; 11:94–101.

6 6. Tullis JL, Tinch RJ, Gibson JG, Baudanza P. A simplified centrifuge for the separation and processing of blood cells. Transfusion 1967; 7:232–242.

7 7. Tullis JL, Eberle WG, Baudanza P, Tinch R. Platelet‐pheresis description of a new technique. Transfusion 1968; 8:154–164.

8 8. Miller WV, Gillem HG, Yankee RA, Schmidt PJ. Pooled platelet concentrates prepared in a new blood bank centrifuge. Transfusion 1969; 9:251–254.

9 9. Szymanski IO, Patti K, Kliman A. Efficacy of the Latham blood processor to perform plateletpheresis. Transfusion 1973; 13:405–411.

10 10. Nusbacher J, Scher ML, MacPherson JL. Plateletpheresis using the Haemonetics Model 30 cell separator. Vox Sang 1977; 33:9–15.

11 11. Glowitz RJ, Slichter SJ. Frequent multiunit plateletpheresis from single donors: effects on donors’ blood and the platelet yield. Transfusion 1980; 20:199–205.

12 12. Lasky LC, Lin A, Kahn RA, McCullough J. Donor platelet response and product quality assurance in plateletpheresis. Transfusion 1981; 21:247–260.

13 13. Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res 1965; 25:1517–1520.

14 14. Buckner D, Eisel R, Perry S. Blood cell separation in the dog by continuous flow centrifugation. Blood 1968; 31:653–672.

15 15. Millward BL, Hoeltge GA. The historical development of automated hemapheresis. J Clin Apher 1982; 1:25–32.

16 16. Graw RG, Herzig GP, Bisel RJ, Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 1971; 11:94–101.

17 17. Jones AL. Continuous‐flow blood cell separation. Transfusion 1968; 8:94–103.

18 18. Hester JP, Kellogg RM, Mulzet AP, et al. Principles of blood separation and component extraction in a disposable continuous‐flow single‐stage channel. Blood 1979; 54:254–268.

19 19. Huestis DW, White RF, Price MJ, Inman M. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor. Transfusion 1975; 15:559–564.

20 20. Sussman LN, Coli W, Pichetshote C. Harvesting of granulocytes using a hydroxyethyl starch solution. Transfusion 1975; 15:461–465.

21 21. Aisner J, Schiffer CA, Wiernik PH. Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis. Br J Haematol 1978; 38:121.

22 22. Ito Y, Suaudeau J, Bowman RL. New flow‐through centrifuge without rotating seals applied to plasmapheresis. Science 1975; 189:999–1000.

23 23. Katz AJ, Genco PV, Blumberg N, et al. Platelet collection and transfusion using the Fenwal CS‐3000 cell separator. Transfusion 1981; 21:560–563.

24 24. Mintz PD, Coletta U. Prospective comparison of plateletpheresis with three cell separators using identical donors. Lab Med 1987; 18:537–539.

25 25. Kalmin ND, Grindon AJ. Comparison of two continuous‐flow cell separators. Transfusion 1983; 23:197–200.

26 26. Benjamin RJ, Rojas P, Christmas S, et al. Plateletpheresis efficiency: a comparison of the Spectra LRS and AMICUS separators. Transfusion 1999; 39:895–899.

27 27. Bueno JL, Barea L, Garcia F, Castro E. A comparison of PLT collections from two apheresis devices. Transfusion 2004; 44:119–124.

28 28. Snyder EL, Mechanic S, Cable R, et al. A comparison of the in vivo recovery and survival of platelets collected using the Amicus, CS‐3000 and Spectra blood cell separators. American Society for Apheresis annual meeting, March 1996, abstract #74.

29 29. Snyder EL, Baril L, Min K, et al. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained using a new separator for autologous PBPC transplantation. Transfusion 2000; 40:961–967.

30 30. Moog R, Franck V, Pierce JA, Muller N. Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC‐reduced RBC apheresis concentrates. Transfusion 2001; 41:1159–1164.

31 31. Snyder EL, Elfath MD, Taylor H. Collection of two units of leukoreduced RBCs from a single donation with a portable multiple‐component collection system. Transfusion 2003; 43:1695–1705.

32 32. Ikeda K, Ohto H, Nemoto K, et al. Collection of MNCs and progenitor cells by two separators for PBPC transplantation: a randomized crossover trial. Transfusion 2003; 43:814–819.

33 33. Aronson CA, Kakaiya RM, Keene J, et al. Consistency of quality control values for automated double red blood cell collections. Transfusion 2006; 47: 42A.

34 34. Picker SM, Rradojska SM, Gathof BS. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage. Transfusion 2007; 47:687–696.

35 35. Simon TL, Sierra ER, Ferdinando B, Moore R. Collection of platelets with a new cell separator and their storage in a citrate‐plasticized container. Transfusion 1991; 31:335–339.

36 36. Elfath MD, Whitley P, Jacobson MS. Evaluation of an automated system for the collection of packed RBCs, platelets, and plasma. Transfusion 2000; 40:1214–1222.

37 37. Burnouf T, Kappelsberger C, Frank K, Burkhardt T. Protein composition and activation markers in plasma collected by three apheresis procedures. Transfusion 2003; 43:1223–1230.

38 38. Snyder EL, Elfath MD, Taylor H, et al. Collection of two units of leukoreduced RBCs from a single donation with a portable multiple‐component collection system. Transfusion 2003; 43:1695–1705.

39 39. Rugg N, Pitman C, Menitove JE, et al. A feasibility evaluation of an automated blood component collection system platelets and red cells. Transfusion 1999; 39:460–464.

40 40. Dumont LJ, Beddard R, Whitley P, et al. Autologous transfusion recovery of WBC‐reduced high‐concentration platelet concentrates. Transfusion 2002; 42(10):1333–1339.

41 41. Burgstaler EA. Blood component collection by apheresis. J Clin Apher 2006; 21:142–151.

42 42. Valbonesi M, Frisoni R, Florio G, et al. Single‐donor platelet concentrates produced along with packed red blood cells with the Haemonetics MCS 3p: preliminary results. J Clin Apher 1994; 9:195–199.

43 43. Moog R, Zeiler T, Geuft HG, et al. Collection of WBC‐reduced single‐donor PLT concentrates with a new blood cell separator: results for a multicenter study. Transfusion 2003; 43:1107–1114.

44 44. Berger K, Schopohl D, Wittmann G, et al. Blood product supply in Germany: the impact of apheresis and pooled platelet concentrates. Transfus Med Hemother 2016; 43:389–394.

45 45. Surgenor DM, Wallace EL, Hao HS, Chapman RH. Collection and transfusion of blood in the United States, 1982–88. N Engl J Med 1990; 322:1646–1652.

46 46. The 2013 National Blood Collection and Utilization Survey Report, Department of Health and Human Services. Conducted under contract (HHSP23320110008TC) with the American Association of Blood Banks, and using OMB Number 0990–0313.

47 47. Gorlin JB, ed. Standards for Blood Banks and Transfusion Services, 26th edn. Bethesda, MD: American Association of Blood Banks, 2009.

48 48. Slichter SJ. Efficacy of platelets collected by semi‐continuous flow centrifugation (Haemonetics Model 30). Br J Haematol 1978; 38:131–140.

49 49. Katz A, Houx J, Ewald L. Storage of platelets prepared by discontinuous flow centrifugation. Transfusion 1978; 18:220–223.

50 50. Patel IP, Ambinder E, Holland JF, Aledort LM. In vitro and in vivo comparison of single‐donor platelets and multiple‐donor pooled platelets transfusions in leukemic patients. Transfusion 1978; 18:116–119.

51 51. Turner VS, Hawker RJ, Mitchell SG, Seymour Mead AM. Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for five days. J Clin Apher 1994; 9:189–194.

52 52. Maguire LC, Henriksen RA, Strauss RG. Function and morphology of platelets produced for transfusion by intermittent‐flow centrifugation plateletpheresis or combined platelet‐leukapheresis. Transfusion 1981; 21:118–123.

53 53. Daly PA, Schiffer CA, Aisner J, Wiernik PH. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis. Transfusion 1979; 19:778–781.

54 54. Rock GA, Blanchette VS, Wong SC. Storage of platelets collected by apheresis. Transfusion 1983; 23:99–105.

55 55. Meyer D, Bolgiano DC, Sayers M, et al. Red cell collection by apheresis technology. Transfusion 1993; 33:819–824.

56 56. Shi PA, Ness PM. Two‐unit red cell apheresis and its potential advantages over traditional whole‐blood donation. Transfusion 1999; 39:219–225.

57 57. Gilcher RO. It’s time to end RBC shortages. Transfusion 2003; 43:1658–1660.

58 58. Smith JW, Gilcher RO. Red blood cells, plasma, and other new apheresis‐derived blood products: improving product quality and donor utilization. Transfus Med Rev 1999; 13:118–123.

59 59. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis‐collected RBC stored for 42 days. Vox Sang 1998; 75:212–217.

60 60. Bandarenko N, Rose M, Kowalsky J, et al. In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in‐line WBC‐reduction filter. Transfusion 2001; 41:1373–1377.

61 61. Hogler W, Mayer W, Messmer C, et al. Prolonged iron depletion after allogeneic 2‐unit RBC apheresis. Transfusion 2001; 41:602–605.

62 62. Benjamin RJ, Ky BA, Kennedy JM, et al. The relative safety of automated two‐unit red blood cell procedures and manual whole‐blood collection in young donors. Transfusion 2009; 49:1874–1883.

63 63. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974; 44:571–581.

64 64. Mishler JM, Higby DJ, Rhomberg W. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator. Transfusion 1974; 14:352–356.

65 65. Mishler JM, Hester JP, Heustis DW, et al. Dosage and scheduling regimens for erythrocyte‐sedimenting macromolecules. J Clin Apher 1983; 1:130–143.

66 66. Lee JH, Cullis H, Leitman SF, Klein HG. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis. J Clin Apher 1995; 10:198–202.

67 67. Strauss RG. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low‐molecular‐weight hydroxyethyl starch. Vox Sang 1979; 37:268–271.

68 68. Ghodsi Z, Strauss RG. Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001; 41:1464–1468.

69 69. Burch JW, Mair DC, Meny GM, et al. The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion 2005; 45:1701–1708.

70 70. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81:1883–1888.

71 71. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony‐stimulating factor. Blood 1993; 81:2866–2871.

72 72. Liles WC, Huang JE, Llewellyn C, et al. A comparative trial of granulocyte‐colony‐stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997; 37:182–187.

73 73. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36:601–610.

74 74. Stroncek DF, Clay ME, Herr G, et al. The kinetics of G‐CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997; 7:19–24.

75 75. Lightfoot T, Leitman SF, Stroncek DF. Storage of G‐CSF‐mobilized granulocyte concentrates. Transfusion 2000; 40:1104–1110.

76 76. Djerassi I, Kim JS, Suvansri U, et al. Continuous flow filtration—leukopheresis. Transfusion 1972; 12:75–83.

77 77. McCullough J, Weiblen BJ, Deinard AR, et al. In vitro function and post‐transfusion survival of granulocytes collected by continuous‐flow centrifugation and by filtration leukapheresis. Blood 1976; 48:315–326.

78 78. Wright DG, Kauffmann JC, Chusid MJ, et al. Functional abnormalities of human neutrophils collected by continuous flow filtration leukopheresis. Blood 1975; 46:901–911.

79 79. Schiffer CA, Aisner J, Wiernik PH. Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood 1975; 45:141–146.

80 80. Rubins JL, MacPherson JL, Nusbacher J, Wiltbank T. Granulocyte kinetics in donors undergoing filtration leukapheresis. Transfusion 1976; 16:56–62.

81 81. Hammerschmidt DE, Craddock PR, McCullough J, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51:721–730.

82 82. Nusbacher J, Rosenfeld SI, MacPherson JL, et al. Nylon fiber leukapheresis: associated complement component changes and granulocytopenia. Blood 1978; 51:359–365.

83 83. Wiltbank TB, Nusbacher J, Higby DJ, MacPherson JL. Abdominal pain in donors during filtration leukapheresis. Transfusion 1977; 17:159–162.

84 84. Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid‐recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977; 297:1033.

85 85. Glasser L. Functional considerations of granulocyte concentrates used for clinical transfusions. Transfusion 1979; 19:1.

86 86. Strauss RG, Maguire LC, Koepke JA, Thompson JS. Properties of neutrophils collected by discontinuous‐flow centrifugation leukapheresis employing hydroxyethyl starch. Transfusion 1979; 19:192.

87 87. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short term storage. Blood 1979; 54:977.

88 88. McCullough J, Weiblen BJ, Fine D. Effects of storage of granulocytes on their fate in vivo. Transfusion 1983; 23:20.

89 89. Dutcher JP, Schiller CA, Johston GS, et al. The effect of histocompatibility factors on the migration of transfused 111indium‐labeled granulocytes (abstract). Blood 1984; 58:181.

90 90. Glasser L. Effect of storage on normal neutrophils collected by discontinuous‐flow centrifugation leukapheresis. Blood 1977; 50:1145.

91 91. McCullough J. Liquid preservation of granulocytes. Transfusion 1980; 20:129.

92 92. McCullough J, Clay ME, Loken MK, Hurd JJ. Effect of ABO incompatibility on fate in vivo of 111indium granulocytes. Transfusion 1988; 28:358.

93 93. Eyre HJ, Goldstein IM, Perry S, Graw RG Jr. Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood 1970; 36:432.

94 94. Applebaum FR, Trapani RJ, Graw RG. Consequences of prior alloimmunization during granulocyte transfusion. Transfusion 1977; 17:460.

95 95. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111indium granulocytes. Blood 1986; 67:522.

96 96. Dutcher JP, Fox JJ, Riggs C, et al. Pulmonary retention of indium‐111‐ labeled granulocytes in alloimmunized patients. Blood 1982; 58:171 (abstract).

97 97. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82:3770–3777.

98 98. Welte K, Gabrilove J, Bronchud MH, et al. Filgrastim (r‐metHuG‐CSF): the first 10 years. Blood 1996; 88:1907–1929.

99 99. Brandt SJ, Peters WP, Atwater SK, et al. Effect of recombinant human granulocyte‐macrophage colony‐stimulating factor on hematopoietic reconstitution after high‐dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318:869–876.

100 100. Bishop MR, Anderson JR, Jackson JD, et al. High‐dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte‐macrophage colony‐stimulating factor on the autograft. Blood 1994; 83:610–616.

101 101. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte‐macrophage colony‐stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991; 324:1773–1778.

102 102. Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81:3158–3163.

103 103. Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor‐derived primitive hematopoietic progenitor cells (CD34+ Th‐1dim) and lymphoid subsets, and possible predictors of engraftment and graft‐versus‐host disease. Blood 1995; 86:2842–2848.

104 104. Bensinger WI, Clift RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 1996; 14:90–105.

105 105. Bensinger WI, Buckner CD, Shannon‐Dorcy K, et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88:4132–4138.

106 106. Nemunaitis J, Anasetti C, Storb R, et al. Phase II trial of recombinant human granulocyte‐macrophage colony‐stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 1992; 79:2572–2577.

107 107. Korbling M, Przepiorka D, Huh YO. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85:1659–1665.

108 108. Lickliter JD, McGlave PB, DeFor TE, et al. Matched‐pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transplant 2000; 26:723–728.

109 109. Schmitz N, Beksac M, Hasenclever D, et al. Transplantation of mobilized peripheral blood cells to HLA‐identical siblings with standard‐risk leukemia. Blood 2002; 100:761–767.

110 110. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97:3380–3389.

111 111. Weaver CH, Buckner CD, Longin K. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony‐stimulating factor. Blood 1993; 82:1981–1984.

112 112. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85:1413–1415.

113 113. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony‐stimulating factor). Blood 1995; 86:1666–1672.

114 114. Hillyer CE, Lackey DA, Hart KK, et al. CD34+ progenitors and colony‐forming units—granulocyte macrophages are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 1993; 33:316–321.

115 115. Stroncek DF, Clay ME, Smith J, et al. Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion 1997; 37:411–417.

116 116. Korbling M, Przepiorka D, Gajewski J, et al. With first successful allogeneic transplantations of apheresis‐derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? Blood 1995; 86:1235–1239.

117 117. Bambi F, Faulkner LB, Azzari C, et al. Pediatric peripheral blood progenitor cell collection: Haemonetics MCS 3P versus COBE Spectra versus Fresenius AS104. Transfusion 1998; 38:70–74.

118 118. Rosenfeld CS, Cullis H, Tarosky T, Nemunaitis J. Peripheral blood stem cell collection using the small volume collection chamber in the Fenwal CS‐3000 Plus blood cell separator. Bone Marrow Transplant 1994; 13; 131–134.

119 119. Hitzler WE, Wolf S, Runkel S, Kunz‐Kostomanolakis M. Comparison of intermittent‐ and continuous‐flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies. Transfusion 2001; 41:1562–1566.

120 120. Morton JA, Baker DP, Hutchins CJ, Durrant ST. The COBE Spectra cell separator is more effective than the Haemonetics MCS‐3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion 1997; 37:631–633.

121 121. Stroncek DF, Clay ME, Smith J, et al. Changes in blood counts after the administration of granulocyte‐colony‐stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996; 36:596–600.

122 122. Platzbecker U, Prange‐Krex G, Bornhauser M, et al. Spleen enlargement in healthy donors during G‐CSF mobilization of PBPCs. Transfusion 2001; 41:184–189.

123 123. Stroncek D, Shawker T, Follman D, et al. G‐CSF‐induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003; 43:609–613.

124 124. Gansner JM, Rahmani M, Jonsson AH, et al. Plateletpheresis‐associated lymphopenia in frequent platelet donors. Blood 2019; 133:605–614.

125 125. Burger SR, Hubel AH, McCullough J. Development of an infusible‐grade solution for non‐cryopreserved hematopoietic cell storage. Cytotherapy 1999; 1:123–133.

126 126. Burnouf T. Modern plasma fractionation. Transfus Med Rev 2007; 21:101–117.

127 127. Runkel S, Hauabelt H, Hitzler W, Hellstern P. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood. Transfusion 2005; 45:427–432.

128 128. Gilcher RO, Gardner JC. Haemonetics V50 and plasma collection system: common concerns and troubleshooting. J Clin Apher 1990; 5:106–109.

129 129. McCombie N, Rock G. Logistics of automated plasma collection. J Clin Apher 1988; 4:104–107.

130 130. Rock G, Tittley P, McCombie N. Plasma collection using an automated membrane device. Transfusion 1986; 26:269–271.